Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Investing In Wine: How To Invest In Wine For Profit

    At a time when the only thing consistent in the stock market is volatility, investing in wine offers you steady profit growth - with a more fun, tasty experience than your typical investment opportunity.

    You can't buy a share of Google and have close friends over to drink some of it. You can, however, have good company over to taste your 1989 Bordeaux. David Sokolin, a highly respected wine merchant with years of experience, states that IGW ("Investment Grade Wines") should return between 10 and 12 percent annually. He also says that they will also do this with lower volatility compared to stocks and bonds. For example, from 2002-2007, Coca-Cola's stock (NYSE:KO) went up 9.72%. If you were to buy a case of 2005 La Mission Haut Brion back in 2008 for $7,800, you might expect it to be valued at $30,000 in the year 2018, a 284.6% gain!

    That's pretty impressive for a bunch of fermented grape juice.

    To continue reading, please click here...


    Read More...
  • buy investing in wine